Natera’s Heart Test Can Better Detect Rejection for Transplant Patients
Natera launched Prospera Heart with Donor Quantity Score, enhancing its ability to detect rejection in heart transplant patients.
Natera launched Prospera Heart with Donor Quantity Score, enhancing its ability to detect rejection in heart transplant patients.
A University of Pittsburgh study not only identifies a warning signal that something is going wrong, but also suggests an existing medication that could be given to patients to aid their long-term recovery.
The Cobas Zika test detects Zika virus RNA in samples of human plasma and is intended for use in screening blood donations.
Rack Reader Traces 2D-Coded Tubes Synchronized reader and software Optimized for rapid and...
Read MoreThe system leverages innovative ultrasound technology to provide rapid viscoelastic results in 15 minutes or less.
Read MoreAssay enables screening for the presence of four clinically relevant species of the Babesia parasite in donated blood.
Read MoreAdoption of the new standards for laboratory connectivity has broad benefits for all stakeholders in the healthcare ecosystem.
Read MoreThe Erytra Eflexis analyzer performs pretransfusion compatibility testing, and can be used in combination with other Grifols blood typing solutions.
Read MoreThe molecular test is the first of its type approved to report genotypes as final results.
Read MoreBlood and test utilization management programs can improve patient care while reducing health system costs.
Read MoreThe molecular red blood cell typing test offers the shortest time to reportable results for US hospitals, reference labs, and blood centers.
Read MoreCareSelect Blood features 100 curated transfusion guidelines authored and maintained by the Mayo Clinic.
Read MoreA noninvasive prenatal test for zygosity in twin pregnancies enables obstetricians to triage patients and avoid both overtreatment and undertreatment.
Read MoreThe research developed an optimized workflow for the recovery and culturing of CTCs from a simple blood test to produce an effective ex vivo culture of an individual patient’s cancer cells.
Read MoreThe customizable middleware system centralizes laboratory operations and workflow across hospitals and networks, allowing blood banks and their data to be confidently managed through one central terminal.
Read MoreMQC-CAT from Hemo Bioscience includes both positive and negative red cells and sera.
Read MoreFor point-of-care hemoglobin testing, good capillary blood sampling practices are vitally important.
Read MoreFDA has approved the Cobas Zika test intended to detect the Zika virus in blood donations.
Read More